Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10745657 | 0.83 | PIN1 (0.53) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL5396329 | 0.82 | POLB (0.60) | PIN1POLBMMP8NPSR1ALDH1A1 | |
| SCHEMBL13625401 | 0.81 | PIN1 (0.51) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL6690054 | 0.81 | POLB (0.46) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL10745489 | 0.80 | PIN1 (0.50) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL9516972 | 0.80 | PIN1 (0.50) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL14510428 | 0.80 | PIN1 (0.50) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL5807773 | 0.80 | PIN1 (0.57) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL13574069 | 0.80 | PIN1 (0.57) | PIN1POLBMMP8NPSR1SMN1; SMN2 | |
| SCHEMBL3948530 | 0.79 | CYP2C19 (0.47) | ALDH1A1KMT2ATSHRMAPTNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7238707-B2 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | SCHERING AG (DE) | 2007-07-03 | — | — | US | disclosed |
| EP-1673344-A1 | 1-(QUINOLINE AMINO) AND 1-(ISOQUINOLINE AMINO)-SUBSTITUTED PENTAN-2-OLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORIES | Schering Aktiengesellschaft (DE) | 2006-06-28 | — | — | EP | disclosed |
| US-20050143415-A1 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | SCHERING AG (DE) | 2005-06-30 | — | — | US | disclosed |
| WO-2005035502-A1 | 1-(QUINOLINE AMINO) AND 1-(ISOQUINOLINE AMINO)-SUBSTITUTED PENTAN-2-OLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORIES | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143415-A1 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | PTGES, TNF, PTGES2 | PIN1 3316/4885POLB 2611/4885MMP8 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.